Clinical Trials Browser

Phase 2 × benralizumab × Other hematologic neoplasm × Clear all

NCT04552288 2025-07-23

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2 Active not recruiting

51 enrolled 8 charts

Other hematologic neoplasm

Hematologic Neoplasms